GALT vs AAPL: Which Stock is Better?
Side-by-side comparison of Galectin Therapeutics Inc and Apple Inc in 2026
GALT
Galectin Therapeutics Inc
$2.45
AAPL
Apple Inc
$270.52
Key Metrics Comparison
| Metric | GALT | AAPL | Winner |
|---|---|---|---|
| Market Cap | $161.28M | N/A | GALT |
| P/E Ratio | N/A | 33.32 | AAPL |
| EPS (TTM) | $N/A | $8.11 | AAPL |
| Revenue Growth | 0.0% | 0.2% | AAPL |
| Gross Margin | 0.0% | 47.3% | AAPL |
Analyze GALT
Full quant analysis
Analyze AAPL
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is GALT or AAPL a better investment?
Comparing GALT and AAPL: Galectin Therapeutics Inc has a market cap of $161.28M while Apple Inc has N/A. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between GALT and AAPL?
GALT (Galectin Therapeutics Inc) and AAPL (Apple Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: GALT or AAPL?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: GALT or AAPL?
AAPL has higher revenue growth at 0.2% vs 0.0% for GALT.
Which company is more profitable: GALT or AAPL?
Apple Inc (AAPL) has higher gross margins at 47.3% compared to 0.0% for GALT.
Which is the larger company: GALT or AAPL?
Galectin Therapeutics Inc (GALT) is larger with a market cap of $161.28M compared to N/A for AAPL.
Should I buy GALT or AAPL in 2026?
Both GALT and AAPL have investment merit. GALT trades at $2.45 while AAPL trades at $270.52. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between GALT and AAPL stock?
Key differences: Market Cap ($161.28M vs N/A), P/E Ratio (N/A vs 33.3x), Revenue Growth (0.0% vs 0.2%), Gross Margin (0.0% vs 47.3%).